Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for medical industry professionals · Friday, April 19, 2024 · 705,010,046 Articles · 3+ Million Readers

Gilles Salles announces the launch of a new subtype driven Lymphoma Hub during ASH 2016

the launch of a new subtype driven Lymphoma Hub during ASH 2016

SAN DIEGO, CALIFORINIA, USA, December 3, 2016 /EINPresswire.com/ -- During the 58th American Society of Haematology (ASH) Annual Meeting in San Diego, CA, Gilles Salles, Chairman of the Lymphoma Hub, announced the launch of an online subtype driven Lymphoma and CLL educational resource called the Lymphoma Hub (www.lymphomahub.com).

Steered by world leaders in Lymphoma and CLL, the Lymphoma Hub now provides the latest treatment options, medical information, case studies, recommendations and expert opinions, structured by subtypes through a variety of digital channels.

Accessible anywhere, users can quickly profile their patient based on the diagnosis to identify the latest treatment options available, whether it be a licensed therapy or a clinical trial currently recruiting.

In Lymphoma and CLL the challenge for a community hematologist or oncologist, as well as fellows, begins at diagnosis. With over 70 different subtypes of Lymphoma in various settings (newly diagnosed or relapsed/refractory), identifying and making the right treatment decision that provides a patient with the best possible outcome is crucial.

In recent years an increase in approvals, line extensions and clinical studies, has meant finding the right treatment has become even more challenging.
The community hematologists and oncologists need a single, credible, up-to-date and practical resource to help them improve their understanding of the new treatment options available in lymphoma and CLL.

The Chairman of the Lymphoma Hub. Gilles Salles. has said the Lymphoma Hub will become: “the reference site for community Hematologist and Oncologists treating Lymphoma and CLL” The Lymphoma Hub supports the community hematologists and oncologists make informed treatment decisions, ensuring patients have access to the latest therapies available.

To view a short video explaining the benefits of the launched subtype driven Lymphoma Hub, visit https://youtu.be/QY_p5Y6ziJ4

Nicholas Walter
Lymphoma Hub Secretariat
+44 (0) 1372 472 153
email us here

Powered by EIN Presswire


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release